A case report highlights the complex interplay between thrombosis and bleeding, emphasizing the need for personalized strategies when resuming anticoagulation after intracerebral haemorrhage.
Case Report (n=1)
How should anticoagulation be managed after intracerebral haemorrhage in patients with prothrombotic risk?
This case underscores the importance of multidisciplinary management and shared decision-making when considering anticoagulation resumption after intracerebral haemorrhage.
The decision to resume anticoagulation after intracerebral haemorrhage is a major clinical challenge, with current evidence offering limited guidance on balancing thrombotic and haemorrhagic risks. We present a case that highlights the intersection of multiple rare but clinically significant conditions against a background of prothrombotic risk. The patient’s course exemplifies the complex interplay between thrombosis and bleeding and the therapeutic dilemmas surrounding the timing and choice of anticoagulation. Current evidence, derived largely from observational cohorts and small randomised trials, supports a reduction in ischaemic events with anticoagulation but consistently demonstrates increased haemorrhagic risk, with limited advice on how best to individualise decisions. This case underscores the importance of multidisciplinary management, shared decision-making and the pressing need for personalised strategies in navigating anticoagulation after intracerebral haemorrhage.
Tanglay et al. (Fri,) conducted a case report in Intracerebral haemorrhage (n=1). Anticoagulation was evaluated. A case report highlights the complex interplay between thrombosis and bleeding, emphasizing the need for personalized strategies when resuming anticoagulation after intracerebral haemorrhage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: